Abstract
Detection of visual field progression remains a challenging task despite the recent advances for better handling of longitudinal visual field data, some of which are incorporated in currently available perimeters. Standard achromatic perimetry remains the gold standard for detection of visual field progression. The authors present a practical and clinically relevant review of the main issues involved in detection of early glaucoma as well as detection of visual field progression in eyes with pre-existing glaucomatous damage. After discussing some basic concepts in perimetry, the authors present evidence-based recommendations for criteria to detect earliest evidence of glaucomatous damage with perimetry. The authors will review different event- and trend-based criteria and present data with regard to comparative performance of such criteria. Relevance of using absolute versus corrected threshold data with regard to different criteria is also addressed. At the end, the authors provide practical guidelines for detection of visual field progression in a clinical setting and review issues related to clinical trials.
Similar content being viewed by others
References
Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR, Kass MA (2002) The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 120:714–720, discussion 829–730
Leske MC, Wu SY, Hyman L, Nemesure B, Hennis A, Schachat AP (2004) Four-year incidence of visual impairment: Barbados Incidence Study of Eye Diseases. Ophthalmology 111:118–124
Harwerth RS, Carter-Dawson L, Shen F, Smith EL 3rd, Crawford ML (1999) Ganglion cell losses underlying visual field defects from experimental glaucoma. Invest Ophthalmol Vis Sci 40:2242–2250
Garway-Heath DF, Caprioli J, Fitzke FW, Hitchings RA (2000) Scaling the hill of vision: the physiological relationship between light sensitivity and ganglion cell numbers. Invest Ophthalmol Vis Sci 41:1774–1782
Quigley HA, Dunkelberger GR, Green WR (1989) Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol 107:453–464
Kerrigan-Baumrind LA, Quigley HA, Pease ME, Kerrigan DF, Mitchell RS (2000) Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest Ophthalmol Vis Sci 41:741–748
Harwerth RS, Carter-Dawson L, Smith EL 3rd, Barnes G, Holt WF, Crawford ML (2004) Neural losses correlated with visual losses in clinical perimetry. Invest Ophthalmol Vis Sci 45:3152–3160
Flammer J, Drance SM, Fankhauser F, Augustiny L (1984) Differential light threshold in automated static perimetry. Factors influencing short-term fluctuation. Arch Ophthalmol 102:876–879
Chauhan BC, LeBlanc RP, Drance SM, Wijsman K, Cruz AM (1991) Effect of the number of threshold determinations on short-term fluctuation in automated perimetry. Ophthalmology 98:1420–1424
Heijl A, Lindgren A, Lindgren G (1989) Test-retest variability in glaucomatous visual fields. Am J Ophthalmol 108:130–135
Boeglin RJ, Caprioli J, Zulauf M (1992) Long-term fluctuation of the visual field in glaucoma. Am J Ophthalmol 113:396–400
Weber J, Rau S (1992) The properties of perimetric thresholds in normal and glaucomatous eyes. Ger J Ophthalmol 1:79–85
Fogagnolo P, Sangermani C, Oddone F, Frezzotti P, Iester M, Figus M, Ferreras A, Romano S, Gandolfi S, Centofanti M, Rossetti L, Orzalesi N (2011) Long-term perimetric fluctuation in patients with different stages of glaucoma. Br J Ophthalmol 95:189–193
Wall M, Kutzko KE, Chauhan BC (1997) Variability in patients with glaucomatous visual field damage is reduced using size V stimuli. Invest Ophthalmol Vis Sci 38:426–435
Spry PG, Johnson CA, McKendrick AM, Turpin A (2001) Variability components of standard automated perimetry and frequency-doubling technology perimetry. Invest Ophthalmol Vis Sci 42:1404–1410
Chauhan BC, Tompkins JD, LeBlanc RP, McCormick TA (1993) Characteristics of frequency-of-seeing curves in normal subjects, patients with suspected glaucoma, and patients with glaucoma. Invest Ophthalmol Vis Sci 34:3534–3540
Henson DB, Chaudry S, Artes PH, Faragher EB, Ansons A (2000) Response variability in the visual field: comparison of optic neuritis, glaucoma, ocular hypertension, and normal eyes. Invest Ophthalmol Vis Sci 41:417–421
Spry PG, Henson DB, Sparrow JM, North RV (2000) Quantitative comparison of static perimetric strategies in early glaucoma: test-retest variability. J Glaucoma 9:247–253
Gardiner SK, Crabb DP (2002) Examination of different pointwise linear regression methods for determining visual field progression. Invest Ophthalmol Vis Sci 43:1400–1407
Chauhan BC, Garway-Heath DF, Goni FJ, Rossetti L, Bengtsson B, Viswanathan AC, Heijl A (2008) Practical recommendations for measuring rates of visual field change in glaucoma. Br J Ophthalmol 92:569–573
Blumenthal EZ, Sample PA, Berry CC, Lee AC, Girkin CA, Zangwill L, Caprioli J, Weinreb RN (2003) Evaluating several sources of variability for standard and SWAP visual fields in glaucoma patients, suspects, and normals. Ophthalmology 110:1895–1902
Maddess T (2011) The influence of sampling errors on test-retest variability in perimetry. Invest Ophthalmol Vis Sci 52:1014–1022
Asman P, Heijl A (1992) Glaucoma Hemifield Test. Automated visual field evaluation. Arch Ophthalmol 110:812–819
Asman P, Heijl A (1993) Arcuate cluster analysis in glaucoma perimetry. J Glaucoma 2:13–20
Hodapp E, Parrish RK II, Anderson DR (1993) Clinical decisions in glaucoma. Mosby, St. Louis
Johnson CA, Sample PA, Cioffi GA, Liebmann JR, Weinreb RN (2002) Structure and function evaluation (SAFE): I. criteria for glaucomatous visual field loss using standard automated perimetry (SAP) and short wavelength automated perimetry (SWAP). Am J Ophthalmol 134:177–185
Sample PA, Medeiros FA, Racette L, Pascual JP, Boden C, Zangwill LM, Bowd C, Weinreb RN (2006) Identifying glaucomatous vision loss with visual-function-specific perimetry in the diagnostic innovations in glaucoma study. Invest Ophthalmol Vis Sci 47:3381–3389
Keltner JL, Johnson CA, Quigg JM, Cello KE, Kass MA, Gordon MO (2000) Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study. Ocular Hypertension Treatment Study Group. Arch Ophthalmol 118:1187–1194
Artes PH, Chauhan BC, Keltner JL, Cello KE, Johnson CA, Anderson DR, Gordon MO, Kass MA (2010) Longitudinal and cross-sectional analyses of visual field progression in participants of the Ocular Hypertension Treatment Study. Arch Ophthalmol 128:1528–1532
Hart WM Jr, Becker B (1982) The onset and evolution of glaucomatous visual field defects. Ophthalmology 89:268–279
Mikelberg FS, Drance SM (1984) The mode of progression of visual field defects in glaucoma. Am J Ophthalmol 98:443–445
Boden C, Blumenthal EZ, Pascual J, McEwan G, Weinreb RN, Medeiros F, Sample PA (2004) Patterns of glaucomatous visual field progression identified by three progression criteria. Am J Ophthalmol 138:1029–1036
Nevalainen J, Paetzold J, Papageorgiou E, Sample PA, Pascual JP, Krapp E, Selig B, Vonthein R, Schiefer U (2009) Specification of progression in glaucomatous visual field loss, applying locally condensed stimulus arrangements. Graefes Arch Clin Exp Ophthalmol 247:1659–1669
Anderson DR, Chauhan B, Johnson C, Katz J, Patella VM, Drance SM (2000) Criteria for progression of glaucoma in clinical management and in outcome studies. Am J Ophthalmol 130:827–829
Lee AC, Sample PA, Blumenthal EZ, Berry C, Zangwill L, Weinreb RN (2002) Infrequent confirmation of visual field progression. Ophthalmology 109:1059–1065
Gardiner SK, Crabb DP (2002) Frequency of testing for detecting visual field progression. Br J Ophthalmol 86:560–564
Schulzer M (1994) Errors in the diagnosis of visual field progression in normal-tension glaucoma. Ophthalmology 101:1589–1594, discussion 1595
Heijl A, Leske MC, Bengtsson B, Hussein M (2003) Measuring visual field progression in the Early Manifest Glaucoma Trial. Acta Ophthalmol Scand 81:286–293
Jansonius NM (2005) Bayes' theorem applied to perimetric progression detection in glaucoma: from specificity to positive predictive value. Graefes Arch Clin Exp Ophthalmol 243:433–437
Wesselink C, Heeg GP, Jansonius NM (2009) Glaucoma monitoring in a clinical setting: glaucoma progression analysis vs nonparametric progression analysis in the Groningen Longitudinal Glaucoma Study. Arch Ophthalmol 127:270–274
Drance S, Anderson DR, Schulzer M (2001) Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol 131:699–708
The Advanced Glaucoma Intervention Study (AGIS): 1. (1994) Study design and methods and baseline characteristics of study patients. Control Clin Trials 15:299–325
Advanced Glaucoma Intervention Study. 2. (1994) Visual field test scoring and reliability. Ophthalmology 101:1445–1455
Gillespie BW, Musch DC, Guire KE, Mills RP, Lichter PR, Janz NK, Wren PA (2003) The collaborative initial glaucoma treatment study: baseline visual field and test-retest variability. Invest Ophthalmol Vis Sci 44:2613–2620
Leske MC, Heijl A, Hyman L, Bengtsson B (1999) Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology 106:2144–2153
Bengtsson B, Lindgren A, Heijl A, Lindgren G, Asman P, Patella M (1997) Perimetric probability maps to separate change caused by glaucoma from that caused by cataract. Acta Ophthalmol Scand 75:184–188
Arnalich-Montiel F, Casas-Llera P, Munoz-Negrete FJ, Rebolleda G (2009) Performance of glaucoma progression analysis software in a glaucoma population. Graefes Arch Clin Exp Ophthalmol 247:391–397
Heijl A, Bengtsson B, Chauhan BC, Lieberman MF, Cunliffe I, Hyman L, Leske MC (2008) A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients. Ophthalmology 115:1557–1565
Nouri-Mahdavi K, Hoffman D, Ralli M, Caprioli J (2007) Comparison of methods to predict visual field progression in glaucoma. Arch Ophthalmol 125:1176–1181
Vesti E, Johnson CA, Chauhan BC (2003) Comparison of different methods for detecting glaucomatous visual field progression. Invest Ophthalmol Vis Sci 44:3873–3879
Kim J, Dally LG, Ederer F, Gaasterland DE, VanVeldhuisen PC, Blackwell B, Sullivan EK, Prum B, Shafranov G, Beck A, Spaeth GL (2004) The Advanced Glaucoma Intervention Study (AGIS): 14. Distinguishing progression of glaucoma from visual field fluctuations. Ophthalmology 111:2109–2116
Nouri-Mahdavi K, Caprioli J, Coleman AL, Hoffman D, Gaasterland D (2005) Pointwise linear regression for evaluation of visual field outcomes and comparison with the advanced glaucoma intervention study methods. Arch Ophthalmol 123:193–199
Holmin C, Krakau CE (1982) Regression analysis of the central visual field in chronic glaucoma cases. A follow-up study using automatic perimetry. Acta Ophthalmol (Copenh) 60:267–274
Krakau CE (1985) A statistical trap in the evaluation of visual field decay. Acta Ophthalmol Suppl 173:19–21
Noureddin BN, Poinoosawmy D, Fietzke FW, Hitchings RA (1991) Regression analysis of visual field progression in low tension glaucoma. Br J Ophthalmol 75:493–495
Smith SD, Katz J, Quigley HA (1996) Analysis of progressive change in automated visual fields in glaucoma. Invest Ophthalmol Vis Sci 37:1419–1428
Katz J, Gilbert D, Quigley HA, Sommer A (1997) Estimating progression of visual field loss in glaucoma. Ophthalmology 104:1017–1025
Nouri-Mahdavi K, Brigatti L, Weitzman M, Caprioli J (1997) Comparison of methods to detect visual field progression in glaucoma. Ophthalmology 104:1228–1236
Viswanathan AC, Fitzke FW, Hitchings RA (1997) Early detection of visual field progression in glaucoma: a comparison of PROGRESSOR and STATPAC 2. Br J Ophthalmol 81:1037–1042
Wild JM, Hutchings N, Hussey MK, Flanagan JG, Trope GE (1997) Pointwise univariate linear regression of perimetric sensitivity against follow-up time in glaucoma. Ophthalmology 104:808–815
Membrey WL, Poinoosawmy DP, Bunce C, Fitzke FW, Hitchings RA (2000) Comparison of visual field progression in patients with normal pressure glaucoma between eyes with and without visual field loss that threatens fixation. Br J Ophthalmol 84:1154–1158
Membrey WL, Bunce C, Poinoosawmy DP, Fitzke FW, Hitchings RA (2001) Glaucoma surgery with or without adjunctive antiproliferatives in normal tension glaucoma: 2 Visual field progression. Br J Ophthalmol 85:696–701
Lachenmayr BJ, Kiermeir U, Kojetinsky S (1995) Points of a normal visual field are not statistically independent. Ger J Ophthalmol 4:175–181
Heijl A, Lindgren G, Olsson J (1987) Normal variability of static perimetric threshold values across the central visual field. Arch Ophthalmol 105:1544–1549
Rasker MT, van den Enden A, Bakker D, Hoyng PF (2000) Rate of visual field loss in progressive glaucoma. Arch Ophthalmol 118:481–488
Caprioli J, Mock D, Bitrian E, Afifi AA, Yu F, Nouri-Mahdavi K, Coleman AL (2011) A method to measure and predict rates of regional visual field decay in glaucoma. Invest Ophthalmol Vis Sci. 52:4765–73
Chauhan BC, Drance SM, Douglas GR (1990) The use of visual field indices in detecting changes in the visual field in glaucoma. Invest Ophthalmol Vis Sci 31:512–520
Broman AT, Quigley HA, West SK, Katz J, Munoz B, Bandeen-Roche K, Tielsch JM, Friedman DS, Crowston J, Taylor HR, Varma R, Leske MC, Bengtsson B, Heijl A, He M, Foster PJ (2008) Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data. Invest Ophthalmol Vis Sci 49:66–76
Heijl A, Bengtsson B, Hyman L, Leske MC (2009) Natural history of open-angle glaucoma. Ophthalmology 116:2271–2276
Bengtsson B, Heijl A (2008) A visual field index for calculation of glaucoma rate of progression. Am J Ophthalmol 145:343–353
Artes PH, O'Leary N, Hutchison D, Heckler L, Sharpe G, Nicolela MT, Chauhan BC (2011) Properties of the Statpac Visual Field Index. Invest Ophthalmol Vis Sci. 52:4030–8
Casas-Llera P, Rebolleda G, Munoz-Negrete FJ, Arnalich-Montiel F, Perez-Lopez M, Fernandez-Buenaga R (2009) Visual field index rate and event-based glaucoma progression analysis: comparison in a glaucoma population. Br J Ophthalmol 93:1576–1579
Caprioli J, Spaeth GL (1985) Static threshold examination of the peripheral nasal visual field in glaucoma. Arch Ophthalmol 103:1150–1154
Chen PP (2002) Correlation of visual field progression between eyes in patients with open-angle glaucoma. Ophthalmology 109:2093–2099
Werner EB, Bishop KI, Koelle J, Douglas GR, LeBlanc RP, Mills RP, Schwartz B, Whalen WR, Wilensky JT (1988) A comparison of experienced clinical observers and statistical tests in detection of progressive visual field loss in glaucoma using automated perimetry. Arch Ophthalmol 106:619–623
Viswanathan AC, Crabb DP, McNaught AI, Westcott MC, Kamal D, Garway-Heath DF, Fitzke FW, Hitchings RA (2003) Interobserver agreement on visual field progression in glaucoma: a comparison of methods. Br J Ophthalmol 87:726–730
Chauhan BC, Drance SM, LeBlanc RP, Lieberman MF, Mills RP, Werner EB (1994) Technique for determining glaucomatous visual field progression by using animation graphics. Am J Ophthalmol 118:485–491
Katz J (2000) A comparison of the pattern- and total deviation-based Glaucoma Change Probability programs. Invest Ophthalmol Vis Sci 41:1012–1016
Manassakorn A, Nouri-Mahdavi K, Koucheki B, Law SK, Caprioli J (2006) Pointwise linear regression analysis for detection of visual field progression with absolute versus corrected threshold sensitivities. Invest Ophthalmol Vis Sci 47:2896–2903
Boden C, Sample PA, Boehm AG, Vasile C, Akinepalli R, Weinreb RN (2002) The structure-function relationship in eyes with glaucomatous visual field loss that crosses the horizontal meridian. Arch Ophthalmol 120:907–912
Asman P, Heijl A (1994) Diffuse visual field loss and glaucoma. Acta Ophthalmol (Copenh) 72:303–308
Chauhan BC, LeBlanc RP, Shaw AM, Chan AB, McCormick TA (1997) Repeatable diffuse visual field loss in open-angle glaucoma. Ophthalmology 104:532–538
Drance SM (1991) Diffuse visual field loss in open-angle glaucoma. Ophthalmology 98:1533–1538
Henson DB, Artes PH, Chauhan BC (1999) Diffuse loss of sensitivity in early glaucoma. Invest Ophthalmol Vis Sci 40:3147–3151
Artes PH, Nicolela MT, LeBlanc RP, Chauhan BC (2005) Visual field progression in glaucoma: total versus pattern deviation analyses. Invest Ophthalmol Vis Sci 46:4600–4606
Asman P, Wild JM, Heijl A (2004) Appearance of the pattern deviation map as a function of change in area of localized field loss. Invest Ophthalmol Vis Sci 45:3099–3106
Henson DB, Spenceley SE, Bull DR (1996) Spatial classification of glaucomatous visual field loss. Br J Ophthalmol 80:526–531
Brigatti L, Nouri-Mahdavi K, Weitzman M, Caprioli J (1997) Automatic detection of glaucomatous visual field progression with neural networks. Arch Ophthalmol 115:725–728
Lin A, Hoffman D, Gaasterland DE, Caprioli J (2003) Neural networks to identify glaucomatous visual field progression. Am J Ophthalmol 135:49–54
Goldbaum MH, Sample PA, Chan K, Williams J, Lee TW, Blumenthal E, Girkin CA, Zangwill LM, Bowd C, Sejnowski T, Weinreb RN (2002) Comparing machine learning classifiers for diagnosing glaucoma from standard automated perimetry. Invest Ophthalmol Vis Sci 43:162–169
Sample PA, Goldbaum MH, Chan K, Boden C, Lee TW, Vasile C, Boehm AG, Sejnowski T, Johnson CA, Weinreb RN (2002) Using machine learning classifiers to identify glaucomatous change earlier in standard visual fields. Invest Ophthalmol Vis Sci 43:2660–2665
Goldbaum MH (2005) Unsupervised learning with independent component analysis can identify patterns of glaucomatous visual field defects. Trans Am Ophthalmol Soc 103:270–280
Sample PA, Boden C, Zhang Z, Pascual J, Lee TW, Zangwill LM, Weinreb RN, Crowston JG, Hoffmann EM, Medeiros FA, Sejnowski T, Goldbaum M (2005) Unsupervised machine learning with independent component analysis to identify areas of progression in glaucomatous visual fields. Invest Ophthalmol Vis Sci 46:3684–2692
Nouri-Mahdavi K, Hoffman D, Gaasterland D, Caprioli J (2004) Prediction of visual field progression in glaucoma. Invest Ophthalmol Vis Sci 45:4346–4351
Fitzke FW, Hitchings RA, Poinoosawmy D, McNaught AI, Crabb DP (1996) Analysis of visual field progression in glaucoma. Br J Ophthalmol 80:40–48
Strouthidis NG, Scott A, Viswanathan AC, Crabb DP, Garway-Heath DF (2007) Monitoring glaucomatous visual field progression: the effect of a novel spatial filter. Invest Ophthalmol Vis Sci 48:251–257
Diaz-Aleman VT, Anton A, de la Rosa MG, Johnson ZK, McLeod S, Azuara-Blanco A (2009) Detection of visual-field deterioration by Glaucoma Progression Analysis and Threshold Noiseless Trend programs. Br J Ophthalmol 93:322–328
Bengtsson B, Patella VM, Heijl A (2009) Prediction of glaucomatous visual field loss by extrapolation of linear trends. Arch Ophthalmol 127:1610–1615
Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E (2003) Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial. Arch Ophthalmol 121:48–56
De Moraes CG, Prata TS, Tello C, Ritch R, Liebmann JM (2009) Glaucoma with early visual field loss affecting both hemifields and the risk of disease progression. Arch Ophthalmol 127:1129–1134
Miglior S, Torri V, Zeyen T, Pfeiffer N, Vaz JC, Adamsons I (2007) Intercurrent factors associated with the development of open-angle glaucoma in the European Glaucoma Prevention Study. Am J Ophthalmol 144:266–275
Kunimatsu S, Suzuki Y, Shirato S, Araie M (2000) Usefulness of gaze tracking during perimetry in glaucomatous eyes. Jpn J Ophthalmol 44:190–191
Jansonius NM (2010) On the accuracy of measuring rates of visual field change in glaucoma. Br J Ophthalmol 94:1404–1405
Jansonius NM (2006) Towards an optimal perimetric strategy for progression detection in glaucoma: from fixed-space to adaptive inter-test intervals. Graefes Arch Clin Exp Ophthalmol 244:390–393
Jansonius NM (2007) Progression detection in glaucoma can be made more efficient by using a variable interval between successive visual field tests. Graefes Arch Clin Exp Ophthalmol 245:1647–1651
Financial interest
The authors have no financial interest in the products mentioned in this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nouri-Mahdavi, K., Nassiri, N., Giangiacomo, A. et al. Detection of visual field progression in glaucoma with standard achromatic perimetry: A review and practical implications. Graefes Arch Clin Exp Ophthalmol 249, 1593–1616 (2011). https://doi.org/10.1007/s00417-011-1787-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-011-1787-5